Loading data for XBIT — first visit, this takes a few seconds.
XBiotech Inc. (XBIT)
NasdaqGS: XBIT
· Real-Time Price · USD
2.27
-0.03 (-1.30%)
At close: Aug 28, 2026, 8:00 PM
2.29
+0.88%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
XBiotech Inc. (XBIT) Stock Price, Analysis & Data
-1.30% (1D)
No data available
| Bid | 1.67 |
| Market Cap | 69.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -45.13M |
| 0.85 | |
| -1.46 | |
| n/a | |
| 17.46 | |
| P/B (ttm) | 0.54 |
| P/S (ttm) | n/a |
| Earnings Date | May 11, 2020 |
| Ask | 2.96 |
| Volume | 6,960 |
| Avg. Volume (20D) | 34,053 |
| Open | 2.32 |
| Previous Close | 2.30 |
| Day's Range | 2.26 - 2.32 |
| 52-Week Range | 2.09 - 3.44 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | Jul 15, 2021 |
About XBIT
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malai...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 15, 2015
Employees 87
Stock Exchange NasdaqGS
Ticker Symbol XBIT
Website https://www.xbiotech.com
Financial Performance
In 2025, XBiotech's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -45.54M, an increase of 18.19%.
Financial StatementsEarnings Surprise
XBiotech has released their quarterly earnings on Mar 16, 2020:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.28 misses estimates by -0.13, with 45.10% YoY growth.
XBiotech Inc. is scheduled to release its earnings on May 11, 2020, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
